Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenold Regulatory News (RNO)

Share Price Information for Renold (RNO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 50.60
Bid: 51.00
Ask: 52.00
Change: 0.00 (0.00%)
Spread: 1.00 (1.961%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 50.60
RNO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

17 Nov 2015 07:01

RNS Number : 9022F
Renold PLC
17 November 2015
 

Renold plc

("Renold", "the Company" or "the Group")

 

Proposed acquisition of Aventics TC ("the Acquisition")

Renold, a leading international supplier of industrial chains and related power transmission products, is pleased to announce that it has signed a conditional sale and purchase agreement to acquire the business and trading assets of Aventics Tooth Chain ("Aventics TC"), an operating division of Aventics Gmbh based in Germany, for up to €6.3 million (£4.5 million) in cash.

 

The consideration (on a cash and debt free basis) will be satisfied by an initial payment of €4.8 million at completion followed by further expected payments of up to €1.5 million over the two year period following completion, contingent on achieving certain sales targets. All payments will be satisfied from the Group's existing banking facilities. Completion of the Acquisition is expected to occur after the statutory 'TUPE' consultation period with the employees in Germany and after certain carve out activities have been completed to separate the business from Aventics.

 

As a division of Aventics Gmbh, Aventics TC does not prepare separate audited accounts. Based on financial information obtained by Renold during the due diligence process, third-party sales in the year to 31 December 2014 were €7.5 million (£5.3 million). In addition, approximately €1.5 million (£1.0 million) of sales were delivered indirectly via other Aventics group companies and plans are in place to transition this indirect business to Renold as part of the post closing process. On a proforma basis, Aventics TC made an operating profit before exceptional items of €1.1 million (£0.8 million) in the year ended 31 December 2014. Gross assets at that date were €1.7 million (£1.2 million).

 

Renold anticipates that the Acquisition will be broadly neutral for adjusted earnings in the current financial year, as a result of the business separation costs to be incurred, but should be earnings enhancing thereafter. The Acquisition constitutes a Class 2 transaction for the purposes of the UK Financial Authority's Listing Rules and, as such, does not require Renold shareholders' approval.

 

Aventics TC

Aventics TC is the market leader in the manufacture of inverted tooth chain for industrial applications. Tooth chain is a specialist product not currently manufactured by Renold and is typically seen in applications such as bottling plants and other manufacturing facilities and equipment. The business employs 65 people and operates from a self-contained rented facility in Gronau, Lower Saxony with its own dedicated manufacturing, engineering and sales teams. Two thirds of Aventics TC sales are currently made in Germany with the balance of sales being made in a wide range of international territories including other western European countries, the USA and China. The business operates as a niche division of Aventics Gmbh which specialises in pneumatics equipment and shares certain sales and back office processes with the Aventics Group as a whole.

 

Benefits of the acquisition

Through the Acquisition of Aventics TC, Renold will gain access to a high value-added product not currently part of the Renold offering. Renold expects to expand sales through the existing Renold global sales presence and network which will allow access to a much wider geographical market than currently. In addition, as the factory is close to Renold's plant in Einbeck, Germany, the business will be able to share expertise and some infrastructure services within the more substantial Renold Group.

 

Robert Purcell, Chief Executive of Renold, said:

"The purchase of Aventics TC is an excellent fit with Phase 3 of our STEP 2020 Strategic Plan (the 'Acquisitions' Phase). Aventics TC manufactures a specialist, high quality product which will expand our existing product offering whilst Renold's international footprint will, over time, give the Tooth Chain business access to new customers and geographies."

 

17 November 2015

 

ENQUIRIES:

 

Renold plc

0161 498 4500

Robert Purcell, Chief Executive

Brian Tenner, Finance Director

Arden Partners

020 7614 5917

Chris Hardie

Instinctif Partners

020 7457 2020

Mark Garraway

Helen Tarbet

 

 

 

 

 

 

 

 

 

 

 

 

NOTES FOR EDITORS

 

Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers and distributors. The Company has a well deserved reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.

 

Further information about Renold can be found on the website at: www.renold.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQUNVNRVRAAAAA
Date   Source Headline
5th Feb 202112:26 pmRNSHolding(s) in Company
29th Jan 20217:00 amRNSHolding(s) in Company
13th Jan 20217:00 amRNSTrading Update
17th Dec 20207:00 amRNSBlock listing Interim Review
26th Nov 20207:00 amRNSPreference Stock Dividend
23rd Nov 20204:15 pmRNSHolding(s) in Company
20th Nov 20207:00 amRNSAppointment of Non-Executive Director
18th Nov 20204:15 pmRNSHolding(s) in Company
16th Nov 20207:00 amRNSGrant of Awards – Performance Share Plan
11th Nov 20207:00 amRNSHalf-year Report
16th Oct 20207:00 amRNSTrading Update
1st Oct 20208:41 amRNSGrant of Awards - Performance Share Plan
24th Sep 20207:00 amRNSRe: Directorate Change
22nd Sep 20203:20 pmRNSDirector/PDMR Shareholding
18th Sep 20203:50 pmRNSDirector/PDMR Shareholding
11th Aug 20207:00 amRNSPDMR/Directorate Change
24th Jul 20201:23 pmRNSResult of AGM
24th Jul 20207:00 amRNSAGM Statement
26th Jun 20202:57 pmRNSAnnual Report and Accounts
24th Jun 20204:41 pmRNSSecond Price Monitoring Extn
24th Jun 20204:37 pmRNSPrice Monitoring Extension
18th Jun 202010:37 amRNSDirector/PDMR Shareholding
18th Jun 20208:00 amRNSBlock listing Interim Review
17th Jun 202011:12 amRNSDirector/PDMR Shareholding
16th Jun 20207:00 amRNSFinal Results
28th May 20203:41 pmRNSHolding(s) in Company
27th May 20207:00 amRNSPreference Stock Dividend
12th May 20207:00 amRNSDirectorate Change
10th Mar 20207:00 amRNSDirector/PDMR Shareholding
2nd Mar 20202:21 pmRNSDirector/PDMR Shareholding
28th Feb 20207:00 amRNSTrading Update and Impact of Coronavirus
18th Dec 20197:00 amRNSBlock listing Interim Review
27th Nov 20197:00 amRNSPreference Stock Dividend
22nd Nov 20193:00 pmRNSGrant of Award - Performance Share Plan
18th Nov 20199:27 amRNSHolding(s) in Company
13th Nov 20197:00 amRNSDirectorate Changes
13th Nov 20197:00 amRNSHalf-year Report
30th Oct 201912:07 pmRNSSecond Price Monitoring Extn
30th Oct 201912:02 pmRNSPrice Monitoring Extension
14th Oct 20197:00 amRNSTrading Update
20th Sep 20194:58 pmRNSResult of AGM (replacement)
20th Sep 20192:07 pmRNSResult of AGM
27th Aug 20194:05 pmRNSRevised 2019 Annual Report and Accounts
27th Aug 20197:00 amRNSCompletion of investigation
21st Aug 201912:04 pmRNSHolding(s) in Company
17th Jul 20191:23 pmRNSAdjournment of Annual General Meeting 2019
12th Jul 20199:30 amRNSHolding(s) in Company
10th Jul 20199:10 amRNSDirector/PDMR Shareholding
9th Jul 20197:00 amRNSPostponement of Annual General Meeting
19th Jun 20197:00 amRNSBlock Listing Application

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.